BRPI0213564B8 - formulação depósito e micropartícula compreendendo iloperidona e polímero poli(d,l-lactídeo-co-glicolídeo), e processo para preparação da referida micropartícula - Google Patents
formulação depósito e micropartícula compreendendo iloperidona e polímero poli(d,l-lactídeo-co-glicolídeo), e processo para preparação da referida micropartículaInfo
- Publication number
- BRPI0213564B8 BRPI0213564B8 BRPI0213564A BR0213564A BRPI0213564B8 BR PI0213564 B8 BRPI0213564 B8 BR PI0213564B8 BR PI0213564 A BRPI0213564 A BR PI0213564A BR 0213564 A BR0213564 A BR 0213564A BR PI0213564 B8 BRPI0213564 B8 BR PI0213564B8
- Authority
- BR
- Brazil
- Prior art keywords
- microparticle
- polymer
- iloperidone
- glycolide
- lactide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33903601P | 2001-10-30 | 2001-10-30 | |
PCT/EP2002/012073 WO2003037337A1 (en) | 2001-10-30 | 2002-10-29 | Depot formulations of iloperidone and a star polymer |
Publications (3)
Publication Number | Publication Date |
---|---|
BR0213564A BR0213564A (pt) | 2004-08-31 |
BRPI0213564B1 BRPI0213564B1 (pt) | 2016-08-02 |
BRPI0213564B8 true BRPI0213564B8 (pt) | 2021-05-25 |
Family
ID=23327202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0213564A BRPI0213564B8 (pt) | 2001-10-30 | 2002-10-29 | formulação depósito e micropartícula compreendendo iloperidona e polímero poli(d,l-lactídeo-co-glicolídeo), e processo para preparação da referida micropartícula |
Country Status (12)
Country | Link |
---|---|
US (2) | US7767230B2 (pt) |
EP (2) | EP1441727B1 (pt) |
JP (1) | JP5067998B2 (pt) |
CN (2) | CN1578664A (pt) |
AT (1) | ATE493129T1 (pt) |
BR (1) | BRPI0213564B8 (pt) |
CA (1) | CA2463158C (pt) |
CY (1) | CY1111357T1 (pt) |
DE (1) | DE60238780D1 (pt) |
ES (2) | ES2436439T3 (pt) |
HK (2) | HK1068263A1 (pt) |
WO (1) | WO2003037337A1 (pt) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU782714B2 (en) * | 1999-09-09 | 2005-08-25 | Regents Of The University Of California, The | Cationic liposome delivery of taxanes to angiogenic blood vessels |
WO2003037337A1 (en) * | 2001-10-30 | 2003-05-08 | Novartis Ag | Depot formulations of iloperidone and a star polymer |
GB0216416D0 (en) * | 2002-07-15 | 2002-08-21 | Novartis Ag | Organic compounds |
US20100063093A1 (en) | 2007-03-28 | 2010-03-11 | Curt Wolfgang | Methods for the administration of iloperidone |
CA3113166A1 (en) | 2004-09-30 | 2006-04-13 | Vanda Pharmaceuticals Inc. | Methods for the administration of iloperidone |
DE102005051342A1 (de) * | 2005-10-25 | 2007-04-26 | Goldschmidt Gmbh | Verkapselung und kontrollierte Freisetzung biologisch aktiver Wirkstoffe mit enzymatisch abbaubaren hyperverzweigten Trägerpolymeren |
JP5264492B2 (ja) | 2005-10-25 | 2013-08-14 | エボニック デグサ ゲーエムベーハー | 超分岐ポリマーを含有する調製物 |
EP2029136A4 (en) | 2006-05-22 | 2010-01-06 | Vanda Pharmaceuticals Inc | TREATMENT FOR DEPRESSION DISEASES |
CN100460441C (zh) * | 2006-09-25 | 2009-02-11 | 南开大学 | 生物可降解星型结构聚乙丙交酯载药微球及其制备方法 |
WO2008054725A2 (en) | 2006-10-31 | 2008-05-08 | Surmodics Pharmaceuticals, Inc. | Spheronized polymer particles |
CA2698534C (en) * | 2007-09-10 | 2018-10-09 | Vanda Pharmaceuticals, Inc. | Prediction of qt prolongation based on snp genotype |
SI2222300T1 (sl) | 2007-12-13 | 2014-11-28 | Vanda Pharmaceuticals Inc. | Postopek in sestavek za zdravljenje stanja, posredovanega z receptorjem serotonina |
JP5729808B2 (ja) * | 2007-12-13 | 2015-06-03 | ヴァンダ ファーマシューティカルズ インコーポレイテッド | αアドレナリン受容体介在状態を治療する方法及び組成物 |
WO2011009102A1 (en) | 2009-07-16 | 2011-01-20 | Vanda Pharmaceuticals Inc. | Use of a melatonin agonist for the treatment of sleep disorders including primary insomnia |
MX2012007365A (es) * | 2009-12-23 | 2012-08-15 | Lupin Ltd | Composiciones farmaceuticas de liberacion lenta de iloperidona. |
CN102311430A (zh) * | 2010-06-29 | 2012-01-11 | 大道隆达(北京)医药科技发展有限公司 | 伊潘立酮的新晶态及其制备方法 |
WO2012123963A2 (en) * | 2011-02-24 | 2012-09-20 | Megafine Pharma (P) Ltd. | A process for preparation of iloperidone and amorphous co- precipitate of iloperidone with pharmaceutically acceptable excipient |
US11918557B2 (en) | 2012-01-26 | 2024-03-05 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
CA2861111C (en) | 2012-01-26 | 2021-11-23 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
CA2872324C (en) | 2012-05-18 | 2017-06-06 | Vanda Pharmaceuticals Inc. | Metabolites of (1r-trans)-n-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide |
ES2805376T3 (es) | 2012-12-18 | 2021-02-11 | Vanda Pharmaceuticals Inc | Tasimelteón para el tratamiento de trastornos del ritmo circadiano |
US10376487B2 (en) | 2013-11-12 | 2019-08-13 | Vanda Pharmaceuticals Inc. | Method of treatment |
US11090285B2 (en) | 2013-11-12 | 2021-08-17 | Vanda Pharmaceuticals Inc | Treatment of circadian rhythm disorders |
CN103599074A (zh) * | 2013-11-26 | 2014-02-26 | 重庆医药工业研究院有限责任公司 | 一种伊潘立酮缓释微球及其制备方法 |
CN104352443A (zh) * | 2014-10-21 | 2015-02-18 | 河北科技大学 | 伊潘立酮缓释微球及其制备方法 |
KR20170118830A (ko) | 2015-02-17 | 2017-10-25 | 반다 파마슈티칼즈, 인코퍼레이티드. | 조현병의 치료를 위한 일로페리돈 |
US11071728B2 (en) | 2015-12-11 | 2021-07-27 | Vanda Pharmaceuticals Inc. | Treatment of schizophrenia |
JP2022510454A (ja) * | 2018-12-04 | 2022-01-26 | バンダ・ファーマシューティカルズ・インコーポレイテッド | イロペリドンの持効性投与 |
US11607408B2 (en) | 2019-10-15 | 2023-03-21 | Vanda Pharmaceuticals Inc. | Method of treatment of schizophrenia |
WO2024137439A1 (en) | 2022-12-19 | 2024-06-27 | Vanda Pharmaceuticals Inc. | Dosage regime of iloperidone for treating bipolar i disorder and schizophrenia |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH656884A5 (de) * | 1983-08-26 | 1986-07-31 | Sandoz Ag | Polyolester, deren herstellung und verwendung. |
DE3511587A1 (de) | 1985-03-27 | 1986-10-02 | Schering AG, Berlin und Bergkamen, 1000 Berlin | Glykoester des estradiols und estriols |
US4886370A (en) | 1987-08-25 | 1989-12-12 | Nkk Corporation | Method for detecting a state of substance existing in pipe |
ES2076253T3 (es) * | 1989-05-19 | 1995-11-01 | Hoechst Roussel Pharma | N-(ariloxialquil)-heteroarilpiperidinas y -heteroarilpiperazinas, un procedimiento para su preparacion y su uso como medicamentos. |
US5776963A (en) * | 1989-05-19 | 1998-07-07 | Hoechst Marion Roussel, Inc. | 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility |
US5364866A (en) | 1989-05-19 | 1994-11-15 | Hoechst-Roussel Pharmaceuticals, Inc. | Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics |
US5538739A (en) | 1989-07-07 | 1996-07-23 | Sandoz Ltd. | Sustained release formulations of water soluble peptides |
MX9203319A (es) | 1990-06-04 | 1992-07-31 | Schering Corp | Metodo para la preparacion de cristales de alfa-2 interferona. |
SK282231B6 (sk) * | 1993-11-19 | 2001-12-03 | Janssen Pharmaceutica N. V. | Farmaceutický prostriedok na liečenie psychotických porúch |
HUP0002106A3 (en) | 1997-05-26 | 2001-11-28 | Akzo Nobel Nv | Aromatic sulfonates of trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1h-dibenz-[2,3:6,7]oxepino[4,5-c]pyrrole and pharmaceutical compositions containing it |
UA72189C2 (uk) | 1997-11-17 | 2005-02-15 | Янссен Фармацевтика Н.В. | Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот |
US5955459A (en) * | 1997-11-26 | 1999-09-21 | Neuromedica, Inc. | Fatty acid-antipsychotic compositions and uses thereof |
US6541606B2 (en) | 1997-12-31 | 2003-04-01 | Altus Biologics Inc. | Stabilized protein crystals formulations containing them and methods of making them |
DE19816070A1 (de) | 1998-04-09 | 1999-10-14 | Aventis Res & Tech Gmbh & Co | Retardtablette hergestellt aus linearen wasserunlöslichen Polysacchariden |
CA2345767A1 (en) * | 1998-10-16 | 2000-04-27 | Paul Leonce Irma De Nijs | Therapy for improving cognition |
AU2001263775A1 (en) | 2000-06-02 | 2001-12-11 | Novo-Nordisk A/S | Glucose dependent release of insulin from glucose sensing insulin derivatives |
DK2305656T3 (da) | 2001-08-31 | 2013-02-11 | Novartis Ag | Optiske isomerer of en iloperidonmetabolit |
WO2003037337A1 (en) * | 2001-10-30 | 2003-05-08 | Novartis Ag | Depot formulations of iloperidone and a star polymer |
GB0216416D0 (en) | 2002-07-15 | 2002-08-21 | Novartis Ag | Organic compounds |
-
2002
- 2002-10-29 WO PCT/EP2002/012073 patent/WO2003037337A1/en active Application Filing
- 2002-10-29 JP JP2003539681A patent/JP5067998B2/ja not_active Expired - Lifetime
- 2002-10-29 AT AT02785330T patent/ATE493129T1/de active
- 2002-10-29 EP EP02785330A patent/EP1441727B1/en not_active Expired - Lifetime
- 2002-10-29 CN CNA028214269A patent/CN1578664A/zh active Pending
- 2002-10-29 EP EP10009932.4A patent/EP2295058B1/en not_active Expired - Lifetime
- 2002-10-29 BR BRPI0213564A patent/BRPI0213564B8/pt not_active IP Right Cessation
- 2002-10-29 CA CA2463158A patent/CA2463158C/en not_active Expired - Lifetime
- 2002-10-29 ES ES10009932.4T patent/ES2436439T3/es not_active Expired - Lifetime
- 2002-10-29 CN CN2010102694146A patent/CN101912367A/zh active Pending
- 2002-10-29 ES ES02785330T patent/ES2358416T3/es not_active Expired - Lifetime
- 2002-10-29 DE DE60238780T patent/DE60238780D1/de not_active Expired - Lifetime
- 2002-10-30 US US10/283,989 patent/US7767230B2/en not_active Expired - Lifetime
-
2005
- 2005-01-14 HK HK05100401.8A patent/HK1068263A1/xx not_active IP Right Cessation
-
2010
- 2010-05-20 US US12/784,251 patent/US8815293B2/en not_active Expired - Lifetime
-
2011
- 2011-03-28 CY CY20111100327T patent/CY1111357T1/el unknown
- 2011-09-14 HK HK11109677.8A patent/HK1155381A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60238780D1 (de) | 2011-02-10 |
CN101912367A (zh) | 2010-12-15 |
HK1155381A1 (en) | 2012-05-18 |
JP5067998B2 (ja) | 2012-11-07 |
ES2436439T3 (es) | 2014-01-02 |
EP1441727A1 (en) | 2004-08-04 |
US20100233217A1 (en) | 2010-09-16 |
ES2358416T3 (es) | 2011-05-10 |
WO2003037337A1 (en) | 2003-05-08 |
WO2003037337A8 (en) | 2004-05-13 |
US7767230B2 (en) | 2010-08-03 |
EP2295058B1 (en) | 2013-09-04 |
EP1441727B1 (en) | 2010-12-29 |
CA2463158C (en) | 2013-07-30 |
CY1111357T1 (el) | 2015-08-05 |
EP2295058A1 (en) | 2011-03-16 |
ATE493129T1 (de) | 2011-01-15 |
BR0213564A (pt) | 2004-08-31 |
BRPI0213564B1 (pt) | 2016-08-02 |
CN1578664A (zh) | 2005-02-09 |
CA2463158A1 (en) | 2003-05-08 |
US20030091645A1 (en) | 2003-05-15 |
JP2005508975A (ja) | 2005-04-07 |
US8815293B2 (en) | 2014-08-26 |
HK1068263A1 (en) | 2005-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0213564B8 (pt) | formulação depósito e micropartícula compreendendo iloperidona e polímero poli(d,l-lactídeo-co-glicolídeo), e processo para preparação da referida micropartícula | |
ATE293437T1 (de) | Polymerteilchen zur arzneimittelabgabe | |
EP1707563A3 (en) | Methods and compositions utilizing quinazolinones | |
ATE445423T1 (de) | Absorbierbare polymere und daraus hergestellte chirurgische artikel | |
DE69731623D1 (de) | Saure Polymilchsäure Polymere | |
ATE290036T1 (de) | Herstellung von poly(trimethylenterephthalat) | |
DE60006005D1 (de) | Kontinuierliches verfahren zur herstellung von poly(trimethylenterephthalat) | |
BR0107942A (pt) | Polìmeros de proteìna de liberação lenta | |
CA2337133A1 (en) | Absorbable polymers and surgical articles fabricated therefrom | |
EP2258348A3 (en) | Method for preparing microparticles having a selected polymer molecular weight | |
NO20010201D0 (no) | Polyesteranalog av poly-L-lysin som en löselig, biodegraderbar genavleveringsbærer | |
WO1999025395A3 (en) | Improved wound dressing device | |
AU4390996A (en) | Biologically degradable polymers, processes for manufacturing the same and the use thereof for producing biodegradable moulded articles | |
AU4062100A (en) | Biodegradable polymer compositions, methods for making same and articles therefrom | |
WO2001085208A3 (en) | Molecular antigen arrays and vaccines | |
HK1093216A1 (en) | Cationic polymers having degradable crosslinks | |
ATE405640T1 (de) | Verfahren zur herstellung von biologisch abbaubarem polyester | |
EP1114839A4 (en) | POLYESTER DIOL, POLYURETHANE OBTAINED FROM SAID DIOL AND SPANDEX FILAMENT THEREOF, AND NEW ACRYLIC COPOLYMER CONTAINING DIALKYLAMINO, POLYESTER COMPOSITION AND SPANDEX COMPOSITION | |
DE60043071D1 (de) | Verwendung von bioabbaubaren kunstoffgegenständen zum servieren von nahrungsmittel | |
WO2001044307A3 (en) | Degradable poly(vinyl alcohol) hydrogels | |
CA2311477A1 (en) | Absorbable block copolymers and surgical articles fabricated therefrom | |
BR0005413B1 (pt) | processo para preparar uma plataforma polimÉrica porosa, biodegradÁvel e biocompatÍvel para engenharia de tecidos. | |
WO2004045633A3 (en) | Pharmaceutical composition comprising octreotide microparticles | |
PT1181941E (pt) | Material de revestimento para a medicina de material reabsorvivel, processo para a sua preparacao e disponibilizacao para a medicina | |
CA2180124A1 (en) | Polyamino Salts of Alpha-Hydroxyacids, Alpha-Ketoacids and Related Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: "PARA: INT. CL. A61K 31/454, 9/16 Ipc: A61K 31/454 (2011.01), A61K 9/16 (2011.01), A61P 2 Free format text: PARA: INT. CL. A61K 31/454, 9/16; A61P 25/18 Ipc: A61K 31/454 (2011.01), A61K 9/16 (2011.01), A61P 2 |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/08/2016, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/10/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 29/10/2022 |